Related references
Note: Only part of the references are listed.Novel smac mimetic ASTX660 (Tolinapant) and TNF-α synergistically induce necroptosis in bladder cancer cells in vitro upon apoptosis inhibition
Lei Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)
Hallmarks of Cancer: New Dimensions
Douglas Hanahan
CANCER DISCOVERY (2022)
Chidamide and mitomycin C exert synergistic cytotoxic effects against bladder cancer cells in vitro and suppress tumor growth in a rat bladder cancer model
Shao-Chuan Wang et al.
CANCER LETTERS (2022)
Urinary biomarkers in bladder cancer: A review of the current landscape and future directions
Kenrick Ng et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein
Parima Udompholkul et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Killing by Degradation: Regulation of Apoptosis by the Ubiquitin-Proteasome-System
Ruqaia Abbas et al.
CELLS (2021)
Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real-time PCR
Reza Yahyazadeh et al.
BMC UROLOGY (2021)
Discovery and Validation of Nitroxoline as a Novel STAT3 Inhibitor in Drug-resistant Urothelial Bladder Cancer
Wenfeng Lin et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Tumor necrosis factor-related apoptosis-inducing ligand as a therapeutic option in urothelial cancer cells with acquired resistance against first-line chemotherapy
Stefan Vallo et al.
ONCOLOGY REPORTS (2020)
Future Therapeutic Directions for Smac-Mimetics
Emma Morrish et al.
CELLS (2020)
ASTX660, an antagonist of cIAP1/2 and XIAP, increases antigen processing machinery and can enhance radiation-induced immunogenic cell death in preclinical models of head and neck cancer
Wenda Ye et al.
ONCOIMMUNOLOGY (2020)
Synthesis and Identification of a Novel Lead Targeting Survivin Dimerization for Proteasome-Dependent Degradation
Robert Peery et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Bladder Cancer: A Review
Andrew T. Lenis et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Inhibitor of apoptosis proteins in human health and disease
Matous Hrdinka et al.
GENES AND IMMUNITY (2019)
The role of necroptosis in cancer biology and therapy
Yitao Gong et al.
MOLECULAR CANCER (2019)
Validation of survivin and HMGA2 as biomarkers for cisplatin resistance in bladder cancer
Ulrich Krafft et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Downregulation of miR-200c stabilizes XIAP mRNA and contributes to invasion and lung metastasis of bladder cancer
Honglei Jin et al.
CELL ADHESION & MIGRATION (2019)
Targeting the BIR Domains of Inhibitor of Apoptosis (IAP) Proteins in Cancer Treatment
Federica Cossu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
Tumor Evolution and Drug Response in Patient-Derived Organoid Models of Bladder Cancer
Suk Hyung Lee et al.
CELL (2018)
Organoid culture of bladder cancer cells
Takahiro Yoshida et al.
INVESTIGATIVE AND CLINICAL UROLOGY (2018)
A subcellular map of the human proteome
Peter J. Thul et al.
SCIENCE (2017)
NF-κB suppresses apoptosis and promotes bladder cancer cell proliferation by upregulating survivin expression in vitro and in vivo
Xiaolu Cui et al.
SCIENTIFIC REPORTS (2017)
Inhibitors of apoptosis: clinical implications in cancer
Mervat S. Mohamed et al.
APOPTOSIS (2017)
Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs)
Rama Rathore et al.
APOPTOSIS (2017)
Smac Mimetics to Therapeutically Target IAP Proteins in Cancer
S. Fulda
INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 330 (2017)
Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
Giuseppa Pistritto et al.
AGING-US (2016)
T1 high-grade bladder carcinoma outcome: the role of p16, topoisomerase-IIα, survivin, and E-cadherin
Maria Rosaria Raspollini et al.
HUMAN PATHOLOGY (2016)
Urinary Biomarkers for Diagnosis of Bladder Cancer A Systematic Review and Meta-analysis
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2015)
The UBC-40 Urothelial Bladder Cancer cell line index: a genomic resource for functional studies
Julie Earl et al.
BMC GENOMICS (2015)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Surface-Modified Nanoparticles Enhance Transurothelial Penetration and Delivery of Survivin siRNA in Treating Bladder Cancer
Darryl T. Martin et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Therapeutic potential of sepantronium bromide YM155 in gemcitabine- resistant human urothelial carcinoma cells
Yen Ta Huang et al.
ONCOLOGY REPORTS (2014)
Small-molecule SMAC mimetics as new cancer therapeutics
Longchuan Bai et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Livin, Survivin and Caspase 3 as early recurrence markers in non-muscle-invasive bladder cancer
Jianwen Wang et al.
WORLD JOURNAL OF UROLOGY (2014)
A Smac mimetic augments the response of urothelial cancer cells to gemcitabine and cisplatin
Eugene K. Lee et al.
CANCER BIOLOGY & THERAPY (2013)
Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer
Ren Chong Xi et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Survivin Signaling in Clinical Oncology: A Multifaceted Dragon
Jagat R. Kanwar et al.
MEDICINAL RESEARCH REVIEWS (2013)
Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients
Xiaochi Chen et al.
ONCOLOGY LETTERS (2013)
IAPS and ubiquitylation
Rebecca Feltham et al.
IUBMB LIFE (2012)
Nuclear cIAP1 overexpression is a tumor stage- and grade-independent predictor of poor prognosis in human bladder cancer patients
Xiangyu Che et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Redirecting neutrophils against bladder cancer cells by BCG and Smac mimetic combination
Goodwin G. Jinesh et al.
ONCOIMMUNOLOGY (2012)
Broad spectrum and potent antitumor activities of YM155, a novel small-molecule survivin suppressant, in a wide variety of human cancer cell lines and xenograft models
Takahito Nakahara et al.
CANCER SCIENCE (2011)
Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2
M. Darding et al.
CELL DEATH AND DIFFERENTIATION (2011)
Research progress on Livin protein: an inhibitor of apoptosis
Biao Yan
MOLECULAR AND CELLULAR BIOCHEMISTRY (2011)
CARD-Mediated Autoinhibition of cIAP1's E3 Ligase Activity Suppresses Cell Proliferation and Migration
Juanita Lopez et al.
MOLECULAR CELL (2011)
RNAi-based Therapeutics Targeting Survivin and PLK1 for Treatment of Bladder Cancer
Shaguna Seth et al.
MOLECULAR THERAPY (2011)
Distinct roles for the cellular inhibitors of apoptosis proteins 1 and 2
T. E. Graber et al.
CELL DEATH & DISEASE (2011)
Suppression of Livin Gene Expression by siRNA Leads to Growth Inhibition and Apoptosis Induction in Human Bladder Cancer T24 Cells
Deyong Yang et al.
BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY (2010)
Assembling the building blocks: structure and function of inhibitor of apoptosis proteins
P. D. Mace et al.
CELL DEATH AND DIFFERENTIATION (2010)
Prognostic significance of second mitochondria-derived activator of caspase (Smac/DIABLO) expression in bladder cancer and target for therapy
Yoichi Mizutani et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2
John W. Blankenship et al.
BIOCHEMICAL JOURNAL (2009)
Immunogenic and tolerogenic cell death
Douglas R. Green et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Synthetic Smac peptide enhances chemo-sensitivity of bladder cancer cells
Jing Wang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2008)
IAP-targeted therapies for cancer
E. C. LaCasse et al.
ONCOGENE (2008)
IAPs as a target for anticancer therapy
S. Danson et al.
CURRENT CANCER DRUG TARGETS (2007)
XIAP as a prognostic marker of early recurrence of nonmuscular invasive bladder cancer
Li Ming et al.
CHINESE MEDICAL JOURNAL (2007)
Survivin expression is associated with bladder cancer presence, stage, progression, and mortality
Shahrokh F. Shariat et al.
CANCER (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Expression of X-linked inhibitor of apoptosis protein and its effect on chemotherapeutic sensitivity of bladder carcinoma
Wang Liang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2007)
Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway
L. Ma et al.
CELL DEATH AND DIFFERENTIATION (2006)
Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)
MC Franklin et al.
BIOCHEMISTRY (2003)
Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer
P Gazzaniga et al.
ANNALS OF ONCOLOGY (2003)
SMAC negatively regulates the anti-apoptotic activity of melanoma inhibitor of apoptosis (ML-LAP)
D Vucic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Livin, a novel inhibitor of apoptosis protein family member
GM Kasof et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli
Y Yang et al.
SCIENCE (2000)
The NACHT family - a new group of predicted NTPases implicated in apoptosis and MHC transcription activation
EV Koonin et al.
TRENDS IN BIOCHEMICAL SCIENCES (2000)
Share Paper
